{"id":"W2981385176","doi":"10.1093/eurheartj/ehz748.0952","title":"P2629Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Medicine; EMPA; Internal medicine; Type 2 diabetes; Adverse effect; Heart failure; Placebo; Diabetes mellitus; Clinical trial; Hazard ratio; Clinical endpoint; Proportional hazards model; Confidence interval; Endocrinology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002527155,0.0009525075,0.001749058,0.0001929326,0.000228562,0.001061184,0.0004938507,0.001019822,0.004265245],"category_scores_gemma":[0.00256992,0.0002166304,0.002942218,0.0003313756,0.0004963791,0.0007329604,0.0004846273,0.00198073,0.000697317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002397447,"about_ca_system_score_gemma":0.0004018318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004156806,"about_ca_topic_score_gemma":0.0006830495,"domain_scores_codex":[0.9991139,0.0005216808,0.00005659034,0.0001368803,0.00009828212,0.0000726775],"domain_scores_gemma":[0.9987204,0.0004401316,0.0003687691,0.0001235416,0.00009065396,0.0002565847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9411346,0.003002864,0.007629495,0.001310466,0.004550048,0.00007973497,0.00003855099,0.0006421102,0.001275952,0.0002010706,0.003549632,0.03658553],"study_design_scores_gemma":[0.8193029,0.08144997,0.08345518,0.0003158806,0.006912324,0.0001762015,0.00006838294,0.002331465,0.0006097359,0.001006272,0.004309999,0.00006173938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691394,0.01685392,0.001069913,0.001406208,0.0005332477,0.0007843222,0.004669601,0.0001296963,0.005413617],"genre_scores_gemma":[0.9872013,0.002891284,0.0008809218,0.001333921,0.0008166557,0.0009310225,0.003971414,0.00002275017,0.001950682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004265245,"threshold_uncertainty_score":0.0142687,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01751661167758685,"score_gpt":0.2341183101580793,"score_spread":0.2166016984804925,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}